A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

Completed · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give one of three different triple-drug combinations to HIV-infected patients who have never been treated with anti-HIV drugs.

Key facts

Study ID

NCT00002407

Run by

Weill Medical College of Cornell University

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have:
• Diagnosed asymptomatic HIV infection.
• HIV-1 RNA greater than 500 copies/ml.
• CD4+ T-cell count greater than 200/mm3.
• Never received antiretroviral therapy.

You may not qualify if…

• Co-existing Condition:
• Excluded:
• Severe non-HIV-related disease.
• Patients with the following prior conditions are excluded:
• History of neuropathy.
• Prior Medication:
• Excluded:
• Investigational drug within 1 month prior to study.
• Immunomodulatory drug within 1 month prior to study.
• Prior Treatment:
• Excluded:
• Radiation therapy within past month.
• Chemotherapy within past month.

Where it is running

• Cornell AIDS Clinical Trials Unit — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.